Prevalence, Treatment and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis

ConclusionIn a large SSc ‐ILD cohort, a significant proportion of patients have coexisting PH, which often occurs early after diagnosis; most patients were treated with ILD and PAH therapies, and survival was good. Patients with SSc‐ILD should be evaluated for coexisting PH.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatology - February 14, 2019 Category: Rheumatology Authors: Amber Young, Dharshan Vummidi, Scott Visovatti, Kate Homer, Holly Wilhalme, Eric S. White, Kevin Flaherty, Vallerie McLaughlin, Dinesh Khanna Tags: Full Length Source Type: research